Indivior /
Opiant Pharmaceuticals, Inc.
Indivior PLC completes merger with Opiant Pharmaceuticals, Inc.
- Price per share
- $8.00/share
- Stage
- Agreement signed




What happened
Indivior PLC’s subsidiary, Indivior Inc., merged with Opiant Pharmaceuticals, Inc., which became a wholly owned subsidiary of Indivior Inc. Opiant stockholders received $20.00 in cash per share, plus a contingent value right tied to product sales milestones.
The contingent value right represents potential payments of up to $8.00 per share.
The source
Everything on this page comes from the source below.
Indivior PLC completes merger with Opiant Pharmaceuticals, Inc.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly